P3 Health Partners Inc.
PIII
$5.02
-$0.01-0.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.15% | 4.20% | 9.79% | 18.48% | 25.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.15% | 4.20% | 9.79% | 18.48% | 25.38% |
| Cost of Revenue | -0.88% | 10.14% | 16.39% | 26.29% | 33.50% |
| Gross Profit | -45.42% | -944.38% | -397.63% | -286.24% | -196.89% |
| SG&A Expenses | -4.11% | -5.12% | -2.87% | -9.29% | -24.40% |
| Depreciation & Amortization | -2.56% | -1.88% | -1.27% | -0.71% | -0.58% |
| Other Operating Expenses | -89.84% | 336.79% | 371.51% | 522.65% | 216.08% |
| Total Operating Expenses | -1.81% | 12.40% | 18.23% | 26.41% | 27.21% |
| Operating Income | -0.19% | -78.73% | -88.32% | -86.15% | -39.44% |
| Income Before Tax | -11.79% | -75.71% | -68.41% | -66.54% | 61.49% |
| Income Tax Expenses | 566.97% | -15.67% | -24.32% | 62.78% | -56.92% |
| Earnings from Continuing Operations | -14.45% | -73.13% | -66.15% | -66.49% | 61.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 5.30% | 50.86% | 43.92% | 35.66% | -71.79% |
| Net Income | -27.61% | -110.10% | -104.58% | -135.14% | 18.71% |
| EBIT | -0.19% | -78.73% | -88.32% | -86.15% | -39.44% |
| EBITDA | -1.68% | -159.28% | -190.14% | -178.80% | -78.28% |
| EPS Basic | -25.62% | -78.59% | -71.31% | -59.32% | 71.99% |
| Normalized Basic EPS | -261.98% | -790.33% | -562.39% | -151.47% | -100.45% |
| EPS Diluted | 15.88% | -11.90% | -20.74% | -16.32% | 54.76% |
| Normalized Diluted EPS | -272.30% | -944.47% | -632.67% | -152.00% | -100.44% |
| Average Basic Shares Outstanding | 13.82% | 24.71% | 26.81% | 41.07% | 74.75% |
| Average Diluted Shares Outstanding | 12.28% | -11.68% | -10.54% | -6.19% | 7.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |